Detection of autoantibodies to nucleolar transcription factor NOR 90/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays

Arthritis and Rheumatism

Volumn 39, Issue 8, 1996, Pages 1313-1318

  Fujii, Takao ^a,b   Mimori, Tsuneyo ^a   Akizuki, Masashi ^a  

^a KEIO UNIVERSITY   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; TRANSCRIPTION FACTOR;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CLINICAL FEATURE; DNA BINDING; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATIC DISEASE; SYSTEMIC SCLEROSIS;

EID: 0029781754     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390808     Document Type: Article

References (17)

1. Rodriguez-Sanchez JL, Gelpi C, Juarez C, Hardin JA: Anti-NOR 90: a new autoantibody in scleroderma that recognized a 90-kDa component of the nucleolus-organizing region of chromatin. J Immunol 139:2579-2584, 1987
2. Chan EKL, Imai H, Hamel JC, Tan EM: Human autoantibody to RNA polymerase I transcription factor hUBF: molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med 174:1239-1244, 1991
3. Jantzen HM, Admon A, Bell SP, Tjian R: Nucleolar transcription factor hUBF contains a DNA binding motif with homology to HMG proteins. Nature 334:831-836, 1990
4. Jantzen HM, Chow AM, King DS, Tjian R: Multiple domains of the RNA polymerase I activator hUBF interact with the TATA-binding protein complex hSL1 to mediate transcription. Genes Dev 6:1950-1963, 1992
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
6. Subcommittee for Scleroderma Criteria for the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
8. Homma M, Tojo T, Akizuki M, Yamagata H: Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol 61 (Suppl):26-27, 1986
9. LeRoy EC, Maricq HR, Kahaleh MB: Undifferentiated connective tissue syndrome. Arthritis Rheum 23:341-343, 1980
10. Kipnis RJ, Craft J, Hardin JA: The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis Rheum 33:1431-1437, 1990
11. Imai H, Fritzler MJ, Neri R, Bombardienri S, Tan EM, Chan EKL: Immunocytochemical characterization of human NOR 90 (upstream binding factor) and associated antigen reactive with autoimmune sera. Mol Biol Rep 19:115-124, 1994
12. Dick T, Mierau R, Sternfeld R, Weiner EM, Genth E: Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR). J Rheumatol 22:67-72, 1995
13. Fritzler MJ, von Muhlen CA, Toffoli SM, Staub HL, Laxer RM: Autoantibodies to the nucleolar organizer region antigen NOR-90 in children with systemic rheumatic diseases. J Rheumatol 22:521-534, 1995
14. Kasturi KN, Hatakeyama A, Spiera H, Bona CA: Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes. J Exp Med 181:1027-1036, 1995
15. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM: Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 31:525-532, 1988
16. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr: Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 37:902-906, 1994
17. Imai H, Orchs RL, Kiyokawa K, Furuta S, Nakamura RM, Tan EM: Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol 140:859-870, 1992